Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321

Watchlist Manager
Shenzhen Chipscreen Biosciences Co Ltd Logo
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Watchlist
Price: 19.56 CNY 0.93%
Market Cap: 8B CNY
Have any thoughts about
Shenzhen Chipscreen Biosciences Co Ltd?
Write Note
Shenzhen Chipscreen Biosciences Co Ltd
/
Cash Flow Statement
/
Cash Paid for Dividends

Shenzhen Chipscreen Biosciences Co Ltd
Cash Paid for Dividends

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shenzhen Chipscreen Biosciences Co Ltd
Cash Paid for Dividends Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Paid for Dividends CAGR 3Y CAGR 5Y CAGR 10Y
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Cash Paid for Dividends
-¥23.8m
CAGR 3-Years
-80%
CAGR 5-Years
-93%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cash Paid for Dividends
-¥652.1m
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cash Paid for Dividends
-¥2.2B
CAGR 3-Years
-56%
CAGR 5-Years
-41%
CAGR 10-Years
-27%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cash Paid for Dividends
-¥1.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-26%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cash Paid for Dividends
-¥3.8B
CAGR 3-Years
9%
CAGR 5-Years
-20%
CAGR 10-Years
-26%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Cash Paid for Dividends
-¥18.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shenzhen Chipscreen Biosciences Co Ltd
Glance View

Market Cap
8B CNY
Industry
Pharmaceuticals

In the bustling city of Shenzhen, often hailed as China's Silicon Valley, Shenzhen Chipscreen Biosciences Co Ltd stands as a testament to innovation in the biopharmaceutical landscape. Founded in 2001, the company embarked on a journey to bridge the gap between cutting-edge bioscience and market needs, focusing on research, development, and commercialization of novel drugs. Chipscreen’s core strength lies in its proprietary chemical genomics-based discovery and development platform, which has carved out a niche in identifying molecular targets and mining drug candidates with high therapeutic potential. The company seamlessly integrates advanced technologies with biotech prowess to design and develop small molecule drugs that address unmet clinical needs, primarily focusing on oncology, autoimmune diseases, and metabolic disorders. The financial engine of Chipscreen Biosciences hums through a well-orchestrated portfolio strategy. By progressing drug candidates through various stages of clinical trials, the company has not only diversified its offerings but also strategically positioned itself in lucrative therapeutic markets. Its revenue model capitalizes on successful product commercialization, primarily through sales of its marketed drugs and royalties from licensing agreements with strategic partners. This collaborative approach enables Chipscreen to maximize its product reach while sharing developmental risks. As the company's innovative therapies gain traction in domestic and global markets, Chipscreen continues its commitment to reinvest in research and development, crafting a sustainable cycle of growth fueled by scientific advancement and strategic acumen.

Intrinsic Value
12.34 CNY
Overvaluation 37%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Shenzhen Chipscreen Biosciences Co Ltd's Cash Paid for Dividends?
Cash Paid for Dividends
-23.8m CNY

Based on the financial report for Sep 30, 2024, Shenzhen Chipscreen Biosciences Co Ltd's Cash Paid for Dividends amounts to -23.8m CNY.

What is Shenzhen Chipscreen Biosciences Co Ltd's Cash Paid for Dividends growth rate?
Cash Paid for Dividends CAGR 5Y
-93%

Over the last year, the Cash Paid for Dividends growth was -41%. The average annual Cash Paid for Dividends growth rates for Shenzhen Chipscreen Biosciences Co Ltd have been -80% over the past three years , -93% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.